Thursday, June 8, 2023
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Clinical Associate Professor
University of Nevada
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Reno, Nevada
Vitreoretinal Surgeon
California Retinal Consultants
Director, California Retina Research Foundation
Santa Barbara, California
Associate Professor of Clinical Ophthalmology
Weill Cornell Medical College
Director of Research, Retina Consultants of Houston
Deputy Chair of Ophthalmology
Blanton Eye Institute and Houston Methodist Hospital
Houston, Texas
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
The PIM planners and others have nothing to disclose.
This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alimera; Allergan; Carl Zeiss Meditec; Thea.
This activity is intended for ophthalmologists and diabetologists/endocrinologists.
The goal of this activity is to disseminate the latest clinical data on emerging agents with novel mechanisms of action for the treatment of diabetic macular edema (DME).
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Clinical Associate Professor
University of Nevada
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Reno, Nevada
Vitreoretinal Surgeon
California Retinal Consultants
Director, California Retina Research Foundation
Santa Barbara, California
Associate Professor of Clinical Ophthalmology
Weill Cornell Medical College
Director of Research, Retina Consultants of Houston
Deputy Chair of Ophthalmology
Blanton Eye Institute and Houston Methodist Hospital
Houston, Texas
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
The PIM planners and others have nothing to disclose.
This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alimera; Allergan; Carl Zeiss Meditec; Thea.
Developed through a partnership between Medscape and Postgraduate Institute for Medicine (PIM)
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.
Credit Statement: This course is COPE approved for 0.75 hours of CE credit. Activity #121461 and Course ID 72020-PS. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.
Reviewed by
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 4/2/2021
Valid for credit through: 4/2/2022
processing....
The goal of this activity is to disseminate the latest clinical data on emerging agents with novel mechanisms of action for the treatment of diabetic macular edema.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
